Shalini Sharp - 10 May 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Reporting relationship: Director
Issuer ticker: DTIL
Reported as of: 10 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 May 2021, 16:09:29 UTC
Next SEC filing: 17 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Dario Scimeca, Attorney-in-Fact for Shalini Sharp

Key filing fact

Shalini Sharp filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 12 May 2021.

Key facts

This page summarizes Shalini Sharp's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 May 2021, 16:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +32,800
Change %
Price: $0.000000
Shares after: 32,800
Date: 10 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,800
Exercise price: $8.07
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of May 10, 2022 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 10, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.